Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New pyrrolidine sulfonamides as TRPV4 antagonists

Dec. 14, 2018

Enrollment opens in two studies of Xhance

Dec. 12, 2018

Novel inhaled PI3Kdelta inhibitor with improved properties for respiratory disease treatment

Dec. 7, 2018

Faron identifies optimal subgroup of patients for Traumakine treatment in INTEREST study

Dec. 5, 2018

Aridis announces new milestones in AR-501 development

Dec. 5, 2018

aTyr Pharma initiates phase Ib/IIa study of ATYR-1923 in patients with pulmonary sarcoidosis

Dec. 5, 2018

European Commission approves label extension for Kalydeco

Nov. 29, 2018

Vertex reports phase III data on VX-659 triple combination regimen for cystic fibrosis

Nov. 28, 2018

Glenmark Pharmaceuticals discovers NADPH oxidase inhibitors

Nov. 28, 2018

Phase I results for PIN-201104 support progression to phase II for asthma

Nov. 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
In monkeys, enhanced TB vaccine dissolves after inducing protection
BioWorld Science
An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...